Literature DB >> 19201054

Decontamination of prion protein (BSE301V) using a genetically engineered protease.

J Dickinson1, H Murdoch, M J Dennis, G A Hall, R Bott, W D Crabb, C Penet, J M Sutton, N D H Raven.   

Abstract

A previous study has demonstrated the potential of alkaline proteases to inactivate bovine spongiform encephalopathy (BSE301V). Here we explored the use of MC3, a genetically engineered variant of Bacillus lentus subtilisin. MC3 was used to digest BSE301V infectious mouse brain homogenate (iMBH). MC3 eliminated all detectable 6H4-immunoreactive material at pH 10 and 12; however, Proteinase K was only partially effective at pH 12. When bioassayed in VM mice, MC3- and Proteinase K-digested iMBH gave respectively 66.6% and 22.7% survival rates. Using a titration series for disease incubation, this equates to a >7log reduction in infectivity for MC3 and >6log reduction for Proteinase K. This study demonstrates the potential for thermostable proteases to be developed as effective inactivation processes for prion agents in healthcare management.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201054     DOI: 10.1016/j.jhin.2008.12.007

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  8 in total

1.  An enzymatic treatment of soil-bound prions effectively inhibits replication.

Authors:  Samuel E Saunders; Jason C Bartz; Kurt C Vercauteren; Shannon L Bartelt-Hunt
Journal:  Appl Environ Microbiol       Date:  2011-05-13       Impact factor: 4.792

2.  Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.

Authors:  Matt Stevenson; Lesley Uttley; Jeremy E Oakley; Christopher Carroll; Stephen E Chick; Ruth Wong
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

Review 3.  Fate of prions in soil: a review.

Authors:  Christen B Smith; Clarissa J Booth; Joel A Pedersen
Journal:  J Environ Qual       Date:  2011 Mar-Apr       Impact factor: 2.751

4.  Degradation of the disease-associated prion protein by a serine protease from lichens.

Authors:  Christopher J Johnson; James P Bennett; Steven M Biro; Juan Camilo Duque-Velasquez; Cynthia M Rodriguez; Richard A Bessen; Tonie E Rocke
Journal:  PLoS One       Date:  2011-05-11       Impact factor: 3.240

5.  Evaluation of a combinatorial approach to prion inactivation using an oxidizing agent, SDS, and proteinase K.

Authors:  Jodi D Smith; Eric M Nicholson; Justin J Greenlee
Journal:  BMC Vet Res       Date:  2013-07-25       Impact factor: 2.741

6.  Stability of BSE infectivity towards heat treatment even after proteolytic removal of prion protein.

Authors:  Jan P M Langeveld; Anne Balkema-Buschmann; Dieter Becher; Achim Thomzig; Romolo Nonno; Olivier Andréoletti; Aart Davidse; Michele A Di Bari; Laura Pirisinu; Umberto Agrimi; Martin H Groschup; Michael Beekes; Jason Shih
Journal:  Vet Res       Date:  2021-04-16       Impact factor: 3.683

7.  Enzymatic activity of a subtilisin homolog, Tk-SP, from Thermococcus kodakarensis in detergents and its ability to degrade the abnormal prion protein.

Authors:  Azumi Hirata; Yuki Hori; Yuichi Koga; Jun Okada; Akikazu Sakudo; Kazuyoshi Ikuta; Shigenori Kanaya; Kazufumi Takano
Journal:  BMC Biotechnol       Date:  2013-02-28       Impact factor: 2.563

8.  Enzymatic formulation capable of degrading scrapie prion under mild digestion conditions.

Authors:  Emeka A Okoroma; Diane Purchase; Hemda Garelick; Roger Morris; Michael H Neale; Otto Windl; Oduola O Abiola
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.